<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE338nnn/GSE338956/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><species>Mus musculus</species><gds_type>Genome binding/occupancy profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE338956</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>mtDNA transfer dynamics in vivo can induce dose-dependent tumor cell dedifferentiation and heterogeneity</name><description>Tumor heterogeneity limits treatment efficacy and drives therapy resistance. Although mitochondrial genome (mtDNA) mutations occur in ~60% of solid tumors, their contribution to heterogeneity is unexplored. We deployed established rho0 B16 melanoma and 4T1 breast cancer mouse models and engineered isogenic tumor cells carrying unique homoplasmic single-nucleotide mtDNA variants used as tracking barcodes. Using single-cell ATAC-seq with mitochondrial genotyping (mtscATAC-seq / mgatk) and single-cell multiome (ATAC + gene expression) profiling, we mapped and quantified horizontal mtDNA exchange within tumors in vivo. Respiration-deficient mutant tumor cells selectively and stably acquired host mtDNA, and mtDNA transfer induced dose-dependent tumor cell dedifferentiation and heterogeneity.</description><dates><publication>2026/08/03</publication></dates><accession>GSE338956</accession><cross_references><GSM>GSM9885555</GSM><GSM>GSM9885547</GSM><GSM>GSM9885549</GSM><GSM>GSM9885548</GSM><GSM>GSM9885550</GSM><GSM>GSM9885552</GSM><GSM>GSM9885551</GSM><GSM>GSM9885554</GSM><GSM>GSM9885553</GSM><GPL>34290</GPL><GSE>338956</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>